HBK Sorce Advisory »

Aquestive Therapeutics shares owned by HBK Sorce Advisory

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by HBK Sorce Advisory from 13F filings

Historical chart of HBK Sorce Advisory investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by HBK Sorce Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by HBK Sorce Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $86k 42k 2.02
2023-09-30 $65k 42k 1.53
2023-06-30 $70k 42k 1.65
2023-03-31 $48k 42k 1.14

More positions owned by HBK Sorce Advisory

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Dimensional Etf Trust Us Large Cap Vec (DFVX)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Apple (AAPL)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Vanguard Index Fds Total Stk Mkt (VTI)
JPMorgan Chase & Co. (JPM)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Spdr Ser Tr Nuveen Blmbrg Mu (TFI)

View all positions for HBK Sorce Advisory

Top funds holding Aquestive Therapeutics

Vanguard Group
Essex Investment Management
Vahanian & Associates Financial Planning
Bracebridge Capital
Janney Montgomery Scott
Marshall Wace
Connor, Clark & Lunn Investment Management
Legato Capital Management
Latash Investments
CI Private Wealth
Citadel Advisors
Two Sigma Investments
Jane Street
Millennium Management
Walleye Trading Advisors

View all funds holding Aquestive Therapeutics